ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228389.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.04366353	Sensitive
ENSG00000228389.1	Ponatinib	Lung squamous cell carcinoma	0.01494051	Resistant